Institute of Glycomics, Griffith University; The Kirby Institute, UNSW Sydney
GoGoVax is a multi-centre, randomised, double-blinded, placebo-controlled clinical trial with 24 months of follow-up. The trial will evaluate the efficacy of a meningococcal B vaccine in the prevention of Neisseria gonorrhoeae infection in gay and bisexual men.
